We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SNTI market cap is 111.64M. The company's latest EPS is USD -1.5530 and P/E is -1.56.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 2.46M | 1.77M | 59k | 1.35M | 0 |
| Operating Income | -33.53M | -17.09M | -20.02M | -19.78M | -18.7M |
| Net Income | -22.05M | -16.64M | -18.21M | -18.72M | -18.72M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 4.29M | 2.56M |
| Operating Income | -3.7M | -70.63M | -92.73M |
| Net Income | -3.86M | -58.21M | -71.06M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Assets | 202.36M | 189.44M | 180.79M | 161.43M | 119.48M |
| Total Liabilities | 48.1M | 49.1M | 53.53M | 49.09M | 52.57M |
| Total Equity | 154.27M | 140.34M | 127.26M | 112.34M | 66.91M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 231.46M | 180.79M | 119.48M |
| Total Liabilities | 10.33M | 53.53M | 52.57M |
| Total Equity | -8.88M | 127.26M | 66.91M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Operating | -15.75M | -25.89M | -34.9M | -16.3M | -52.4M |
| Investing | -18.64M | -32.84M | -81.96M | -9.5M | 30.08M |
| Financing | 118.16M | 117.68M | 118.55M | -35k | 779k |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Operating | -1.14M | -34.9M | -52.4M |
| Investing | -230M | -81.96M | 30.08M |
| Financing | 232.03M | 118.55M | 779k |
| Market Cap | 111.64M |
| Price to Earnings Ratio | -1.56 |
| Price to Sales Ratio | 43.21 |
| Price to Cash Ratio | 3.08 |
| Price to Book Ratio | 1.65 |
| Dividend Yield | - |
| Shares Outstanding | 45.76M |
| Average Volume (1 week) | 379.55k |
| Average Volume (1 Month) | 23.79M |
| 52 Week Change | -66.16% |
| 52 Week High | 10.90 |
| 52 Week Low | 2.111 |
| Spread (Intraday) | 0.4 (14.55%) |
| Company Name | Senti Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.sentibio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
